Tata Steel Limited (‘Company’) has today i.e. on December 31, 2025, completed the acquisition of 43,29,90,000 shares of face value ₹10 each for a consideration of ₹1,099.97 crore in Tata…
Category: Market
Equity markets display resilience despite underperformance: RBI report
Notwithstanding the relative underperformance of Indian equities, steady foreign investor outflows and persistent global economic uncertainty, the equity market has displayed remarkable resilience. Volatility remained subdued compared to other markets,…
Government extends import curbs on low-ash metallurgical coke till June 2026
The government on Wednesday said it is extending import restrictions on low-ash metallurgical coke from January 1 till June 30, 2026. However, the coke with high-ash content (above 18 per…
India lowers sugar sales quota for January
Amid higher production estimates of sugar in the 2025-26 season (October-September), the Indian government has allocated 22 lakh tonnes (lt) of sugar for domestic sales during January, which is 2.2…
Mutual Fund assets grows 19% to ₹81 lakh crore
The assets under management of the domestic mutual fund industry increased 19 per cent year-on-year (y-o-y) to ₹81 lakh crore as of November-end. Out of the total AUM, ₹36 lakh…
Abakkus MF maiden NFO mops up ₹2,468 crore
Abakkus Mutual Fund has mopped-up ₹2,468 crore through its maiden new fund offer of Flexi Cap Fund. The NFO saw participation from nearly 5,518 pin codes from across 2,000 cities.…
Despite gains, Sensex, Nifty end as worst global performer
Markets concluded calendar year 2025 with modest gains but emerged as the worst-performing major market globally in dollar terms, as record foreign outflows and sharp rupee depreciation overshadowed domestic buying…
Chennai real estate developer Casagrand files DRHP for raising ₹1,220 crore
Chennai-based real estate company Casagrand Premier Builder Limited has filed a Draft Red Herring Prospectus (DRHP) with SEBI to raise ₹1,220 crore with a focus on reducing debt. The public…
Corona Remedies shares to list on Monday; GMP signals solid listing. Check price and other key details here
Corona Remedies GMP in focus: Pharmaceutical firm Corona Remedies, whose IPO garnered massive investor interest during its three-day bidding period, with subscription crossing over 144 times, is set to debut…
